Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review.
anti-NMDAR encephalitis
demyelinating disease
multiple sclerosis
mycophenolate mofetil
overlap
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
11
2022
accepted:
11
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
18
2
2023
Statut:
epublish
Résumé
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune-mediated disease characterized by complicated neuropsychiatric symptoms and the detection of cerebrospinal fluid antibodies against the GluN1 subunit of the NMDAR. With the proposed clinical method, more anti-NMDAR encephalitis patients have been discovered since its first report. However, anti-NMDAR encephalitis overlapping with multiple sclerosis (MS) is rare. Herein we report a male patient with anti-NMDAR encephalitis who developed MS in mainland China. Furthermore, we summarized the characteristics of patients who were diagnosed with overlapping MS and anti-NMDAR encephalitis in previous studies. Additionally, we pioneered the use of mycophenolate mofetil in immunosuppressive therapy, providing a novel therapeutic alternative for overlapping anti-NMDAR encephalitis and MS.
Identifiants
pubmed: 36793718
doi: 10.3389/fimmu.2023.1088801
pmc: PMC9923169
doi:
Substances chimiques
Autoantibodies
0
Receptors, N-Methyl-D-Aspartate
0
Types de publication
Review
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1088801Informations de copyright
Copyright © 2023 Liu, Yan, Li, Zhang and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JAMA Neurol. 2015 Jan;72(1):96-9
pubmed: 25384024
Front Immunol. 2022 Apr 22;13:799454
pubmed: 35529871
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 16;7(1):
pubmed: 31619447
BMC Psychiatry. 2021 Jul 12;21(1):347
pubmed: 34247615
Ann Neurol. 2014 Mar;75(3):411-28
pubmed: 24700511
BMJ Case Rep. 2018 Feb 17;2018:
pubmed: 29455177
Neurol Neuroimmunol Neuroinflamm. 2015 Aug 13;2(5):e141
pubmed: 26309901
Front Immunol. 2021 Apr 23;12:664364
pubmed: 33968065
BMC Res Notes. 2014 Dec 23;7:948
pubmed: 25539977
Mult Scler Relat Disord. 2017 Feb;12:20-22
pubmed: 28283100
Neurology. 2013 Oct 29;81(18):1637-9
pubmed: 24089390
Dev Med Child Neurol. 2017 Aug;59(8):796-805
pubmed: 28439890
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):279-83
pubmed: 23704316
Mult Scler Relat Disord. 2020 Jul;42:102075
pubmed: 32388459
Clin Neurol Neurosurg. 2012 May;114(4):402-4
pubmed: 22152786
Neurol Sci. 2021 Jan;42(1):301-303
pubmed: 32989588
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Lancet Neurol. 2018 Sep;17(9):760-772
pubmed: 30049614
Mult Scler Relat Disord. 2014 May;3(3):391-7
pubmed: 25876479
Mov Disord. 2014 Jan;29(1):90-6
pubmed: 24014096
Neurol Sci. 2021 Sep;42(9):3929-3931
pubmed: 34155564
BMJ Neurol Open. 2021 May 18;3(1):e000096
pubmed: 34079936
Neuron. 2006 Apr 6;50(1):9-11
pubmed: 16600850
Lancet Neurol. 2019 Nov;18(11):1045-1057
pubmed: 31326280
Front Immunol. 2020 Dec 09;11:595417
pubmed: 33362777
Lancet Neurol. 2014 Feb;13(2):167-77
pubmed: 24360484